Robert S Kirsner MD PhD

Dermatology•Miami, FL

Chairman and Harvey Blank Professor of Dermatology, University Miami School of Medicine

Join to View Full Profile

1475 NW 12th Ave# M851Miami, FL 33136
Phone+1 305-243-6802
Fax+1 305-243-8470

Education & Training

University of Miami/Jackson Health SystemResidency, Dermatology, 1988 - 1995
University of Miami Leonard M. Miller School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 1990 - 2027
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Top Doctors:South Florida Castle Connolly, 2012
Super Doctor SuperDoctors.com
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Dose Finding Study of HP802-247 in Venous Leg Ulcers Start of enrollment: 2009 Feb 01
Completed
Phase 2
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers Start of enrollment: 2012 Sep 01
Completed
Phase 2
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers Start of enrollment: 2010 Nov 01
Completed
Phase 2
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) Start of enrollment: 2010 Nov 01
Completed
Phase 2
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Start of enrollment: 2012 Nov 01
Completed
Phase 3
Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers Start of enrollment: 2013 Apr 01
Terminated
Phase 3
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers Start of enrollment: 2014 May 01
Unknown status
Phase 3
EZCast-DFU Study With Portal for Application of Topical Medications Start of enrollment: 2014 Oct 01
Completed
Phase 1
VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging Start of enrollment: 2016 Feb 01
Terminated
Not Applicable
Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants Start of enrollment: 2019 Aug 26
Completed
Phase 2
CeraVe Diabetes Mellitus Start of enrollment: 2021 Mar 12
Completed
Phase 4
Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials Start of enrollment: 2021 May 01
TERMINATED
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Sociodemographic predictive factors of increased hospital stay and cost among hospitalised patients with pressure injuries-National Inpatient Sample 2009-2019 (pooled ...
Siri Choragudi, Robert S Kirsner
Wound Repair and Regeneration. 2025-04-22
1 citations
Combined cryotherapy and topical imiquimod, 5-fluorouracil, and tazarotene effectively treats locally advanced basal cell carcinoma and is associated with nearby nodul...
William J Nahm, Olivia L Shen, Robert S Kirsner, Christopher A Mathe, Odysseas V Nikas
JAAD Case Reports. 2025-04-01
Use of Midodrine for Intraoperative Hemostasis in Cutaneous and Percutaneous Surgery.
Joanna Dong, Naiem T Issa, Michael Kaiser, Simonetta I Gaumond, Michael Solis
JID Innovations. 2025-03-01

Journal Articles

Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas
Tim Ioannides, Harold Rabinovitz, Evangelos V Badiavas, Robert S Kirsner, Alyx C Rosen, Wasif N Khan, JAMA
Survival of Children and Young Adults with Skin Cancer: Analysis of a Population‐Based Florida Cancer Registry: 1981‐2013
Kevin J Moore, Robert S Kirsner, Pediatric Dermatology
Dermatology: More Than an Outpatient Specialty
Suchismita Paul, Robert S Kirsner, Journal of The European Academy of Dermatology and Venereology

Lectures

Exercise for Leg Ulcers
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Press Mentions

Would Healing Toolbox Requires Frequent UpdatingDecember 16th, 2024
Wound HealingToolbox Requires Frequent UpdatingDecember 14th, 2024
BPGbio Receives FDA Rare Pediatric Disease Designation for Its Investigational Treatment for Epidermolysis BullosaOctober 31st, 2024
Join now to see all